Skip to main content

CORRECTION article

Front. Pharmacol. , 19 February 2025

Sec. Gastrointestinal and Hepatic Pharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1554390

Corrigendum: Alcohol abstinence rescues hepatic steatosis and liver injury via improving metabolic reprogramming in chronic alcohol-fed mice

Aiwen Pi,,&#x;Aiwen Pi1,2,3Kai Jiang,&#x;Kai Jiang2,4Qinchao Ding,Qinchao Ding1,3Shanglei Lai,Shanglei Lai1,2Wenwen Yang,Wenwen Yang1,2Jinyan Zhu,Jinyan Zhu1,3Rui Guo,Rui Guo1,3Yibin FanYibin Fan5Linfeng Chi
Linfeng Chi6*Songtao Li,,
Songtao Li1,4,3*
  • 1School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China
  • 2School of Life Science, Zhejiang Chinese Medical University, Hangzhou, China
  • 3Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou, China
  • 4Molecular Medicine Institute, Zhejiang Chinese Medical University, Hangzhou, China
  • 5Department of Dermatology, People’s Hospital of Hangzhou Medical College, Zhejiang Provincial People’s Hospital, Hangzhou, China
  • 6School of Basic Medicine, Zhejiang Chinese Medical University, Hangzhou, China

A Corrigendum on
Alcohol Abstinence rescues hepatic steatosis and liver injury via improving metabolic reprogramming in chronic alcohol-fed mice

by Pi A, Jiang K, Ding Q, Lai S, Yang W, Zhu J, Guo R, Fan Y, Chi L and Li S (2021). Front. Pharmacol. 12:752148. doi:10.3389/fphar.2021.752148

In the published article, there was an error in Figure 4 as published. The statistical analysis column chart in Figure 4B was based on the ratio of phosphorylation target proteins to non-phosphorylation of target proteins, but not to internal reference protein GAPDH. To avoid any potential misunderstanding, the band of GAPDH was removed from Figure 4B, as it is unrelated to the quantification of detected proteins.

Figure 4
www.frontiersin.org

Figure 4. Alcohol withdrawal rescues alcohol-stimulated TLR4/MAPKs and mitochondrial apoptotic pathways. Total cellular lysates were extracted from mice liver tissues. (A, B) Immunoblotting assay was performed for TLR-4, p-JNK, p-P38, and p-ERK1/2. (C, D) Immunoblotting assay was performed for P53 and Bax/Bcl-2. *p < 0.05 indicates statistically significant differences (n = 8).

Additionally, the same band of GAPDH was used both in Figures 4C, D, since the bands and data in those panels were based on the same samples with the same loading amount. In order to avoid confusion, we have replaced the band in Figure 4C with other representative images selected from our research records. In the original version, the statistical analysis of data was performed based on all the bands, including previously and currently displayed, therefore, this replacement does not affect the results and conclusions. The corrected Figure 4 and its caption appear below.

‘Alcohol withdrawal rescues alcohol-stimulated TLR4/MAPKs and mitochondrial apoptotic pathways. Total cellular lysates were extracted from mice liver tissues. (A, B) Immunoblotting assay was performed for TLR-4, p-JNK, p-P38, and p-ERK1/2. (C, D) Immunoblotting assay was performed for P53 and Bax/Bcl-2. *p < 0.05 indicates statistically significant differences (n = 8).’

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: alcoholic liver disease, alcohol abstinence, hepatic steatosis, liver injury, hepatic inflammation

Citation: Pi A, Jiang K, Ding Q, Lai S, Yang W, Zhu J, Guo R, Fan Y, Chi L and Li S (2025) Corrigendum: Alcohol abstinence rescues hepatic steatosis and liver injury via improving metabolic reprogramming in chronic alcohol-fed mice. Front. Pharmacol. 16:1554390. doi: 10.3389/fphar.2025.1554390

Received: 02 January 2025; Accepted: 31 January 2025;
Published: 19 February 2025.

Edited and reviewed by:

Zhenyuan Song, University of Illinois Chicago, United States

Copyright © 2025 Pi, Jiang, Ding, Lai, Yang, Zhu, Guo, Fan, Chi and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Songtao Li, bGlzb25ndGFvQHpjbXUuZWR1LmNu; Linfeng Chi, bGluZmVuZ2NoaUB6Y211LmVkdS5jbg==

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more